Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Heart Attack Diagnostic Market Growth From $12.64 Billion In 2026 To $17.9 Billion By 2030 At A CAGR Of 9.1%#_x000D_
The heart attack diagnostic market has experienced robust growth over the past few years. This market is anticipated to increase from $11.54 billion in 2025 to $12.64 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.5%. Factors contributing to its historical growth include an escalating prevalence of cardiovascular conditions, expanded hospital diagnostic services, better access to cardiac imaging, increased recognition of the need for early heart attack detection, and innovations in lab testing._x000D_
_x000D_
The heart attack diagnostic market size is anticipated to experience robust expansion over the coming years, with projections indicating a growth to $17.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. This growth during the forecast period is primarily driven by factors such as a heightened need for swift diagnostic methods, the expanding incorporation of digital health infrastructures, the proliferation of remote cardiac surveillance, increased capital injection into cutting-edge imaging technologies, and the wider embrace of accurate cardiology diagnostic tools. Key developments projected for this period encompass the widespread uptake of AI-powered diagnostic instruments, the growing application of highly sensitive cardiac biomarkers, the progressive inclusion of point-of-care testing apparatus, the broadening scope of non-invasive diagnostic processes, and a sharpened emphasis on prompt emergency diagnostics._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Heart Attack Diagnostic Market Industry Drivers: What’s Behind The Revenue Growth?#_x000D_
The increasing prevalence of cardiac disorders is propelling the growth of the heart attack diagnostics market. Cardiac disorders (CVD) are a group of conditions affecting the heart and blood vessels. Unhealthy eating, inactivity, tobacco use, and alcohol abuse are the primary factors contributing to heart disease and stroke. Heart attack diagnosis aids in analyzing the causes and severity of heart attacks, strokes, and heart failure. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the rising frequency of cardiovascular illnesses will continue to drive the heart attack diagnostics market._x000D_
_x000D_
#Heart Attack Diagnostic Market Segment Analysis: What Are The Core Market Categories?#_x000D_
The heart attack diagnostic market covered in this report is segmented – _x000D_
_x000D_
1) By Test Type: Electrocardiogram (ECG Or EKG), Blood Tests, Echocardiogram, Coronary Catheterization (Angiogram)_x000D_
2) By Procedure: Invasive Procedure, Non-Invasive Procedure_x000D_
3) By End-Use Industry: Hospitals, Ambulatory Surgical Centers, Diagnostics Centers, Other End-Users _x000D_
_x000D_
Subsegments:_x000D_
1) By Electrocardiogram (ECG Or EKG): Resting ECG, Holter Monitor, Event Monitor_x000D_
2) By Blood Tests: Cardiac Biomarkers, Lipid Panel, B-Type Natriuretic Peptide (BNP)_x000D_
3) By Echocardiogram: Transthoracic Echocardiogram (TTE), Transesophageal Echocardiogram (TEE), Doppler Echocardiogram_x000D_
4) By Coronary Catheterization (Angiogram): Coronary Angiography, Right Heart Catheterization, Left Heart Catheterization_x000D_
_x000D_
_x000D_
#Heart Attack Diagnostic Market Growth Trends: What’s Shaping The Future Outlook?_x000D_
Leading companies in the heart attack diagnostics market are developing innovative products, such as tests for detecting coronary heart disease, to cater to broader customer bases, increase sales, and boost revenue. Coronary heart disease (CHD) detection tests refer to medical assessments and diagnostic procedures designed to identify the presence of coronary heart disease, a condition characterized by the narrowing or blockage of coronary arteries that supply blood to the heart muscle. For instance, in August 2023, Cardio Diagnostics Holdings Inc., a US-based biotechnology company, launched PrecisionCHD. The PrecisionCHD test, a groundbreaking innovation, is a blood-based detection method for coronary heart disease (CHD), distinguishing itself as the sole detection technology that seamlessly combines epigenetic and genetic biomarkers with Artificial Intelligence (AI). This unique test requires only a straightforward blood sample, conveniently collected at a doctor’s office or through a simple at-home procedure, and utilizes the same highly scalable laboratory technique employed in COVID-19 testing. With results available for review within a swift 10 business days, the PrecisionCHD test offers a rapid and efficient alternative to traditional first-line CHD detection tools like stress echocardiograms._x000D_
_x000D_
#Heart Attack Diagnostic Market Key Players Shaping Industry Direction#_x000D_
Major companies operating in the heart attack diagnostic market are Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Koninklijke Philips NV, Siemens AG, Canon Medical Systems Corporation, GE Healthcare, Roche Diagnostics, Beckman Coulter Inc., Schiller AG, Becton Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics, Bio-Rad Laboratories Inc., Hitachi Ltd., Toshiba Corp., Fujifilm Holdings, Midmark Corp., Welch Allyn Inc., HILL ROM HOLDINGS Inc., HeartFlow, Cardio Diagnostics Holdings Inc. _x000D_
_x000D_
#View The Full Heart Attack Diagnostic Market Report:#_x000D_
_x000D_
#Heart Attack Diagnostic Market Regional Analysis: Which Region Leads By Revenue?#_x000D_
North America was the largest region in the heart attack diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart attack diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.